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Background
Cervical dystonia (CD) is the most common form of  focal dystonia in 
adults,1 characterized by involuntary sustained or intermittent neck- 
muscle contractions, resulting in abnormal phasic or tonic movements or 
posture of  the head.2 Botulinum neurotoxin (BoNT) injections are con-
sidered the first-line of  treatment for CD due to its high degree of  effec-
tiveness and safety in approximately 80–85% of  the patients, as has been 
demonstrated in numerous controlled clinical studies.3–12 Pain can be a 
prominent symptom in 68–75% of  cases and may cause significant dis-
ability.13 According to the Col-Cap concept, we can recognize 11 (8+3) 
phenomenological forms of  CD.14 Patients may present with head/neck 
movements in three planes: coronal, sagittal, or transverse, resulting in 
turning, tilting, flexion, extension, or a combination of  these postures. 
Prominent anterocollis occurs in about 25% of  CD cases and may be 
either primary or secondary.2 Anterior forms of  CD are considered the 
most difficult to treat because of  the deep cervical muscles that can be 
involved.15 Injections of  superficial cervical flexor muscles, such as ster-
nocleidomastoid (SCM), anterior/middle scalene (AS/MS), or levator 
scapulae (LS), can be only occasionally effective in that variant of  CD. 
We find that longus colli (LCo) injections with fluoroscopy,16 computed 
tomography (CT),17,18 electromyography (EMG)19 or ultrasonography 
(US) guidance20 give satisfying results. Endoscopic guidance can also be 
used for targeting the upper part of  this muscle.21 Anterior Sagittal Shift 
(ASS), known as “goose neck,” is a special form of  CD that combines 
anterocollis and retrocaput. There are different treatment protocols. On 
the basis of  the Col-Cap concept, we should choose the muscles involved 
in these two forms of  CD.22 We can also find another suggestion based on 
EMG functional guidance and inject both SCM and splenius capitis 
muscles.19 We will now describe an injection into the longus colli muscles 
via the thyroid gland in a patient with ASS.
Case report
The patient is a 60-year-old woman who presents with cervical dysto-
nia. The onset was in 2002 and started with neck pain, then she noticed 
flexion of  the neck. We diagnosed ASS (Figure 1A). The patient provided 
written consent to publish her images. The patient underwent several 
treatment sessions with BoNT injections into her neck muscles under 
EMG and/or US control without any significant improvement. She had 
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Abstract
Background:  Anterior forms of  cervical dystonia are considered to be the most difficult to treat because of  the deep cervical muscles that can be involved.
Case Report:  We report the case of  a woman with cervical dystonia who presented with anterior sagittal shift, which required injections through the longus colli 
muscle to obtain a satisfactory outcome. The approach via the thyroid gland was chosen.
Discussion:  The longus colli muscle can be injected under electromyography (EMG), computed tomography (CT), ultrasonography (US), or endoscopy guidance. 
We recommend using both ultrasonography and electromyography guidance as excellent complementary techniques for injection at the C5-C6 level.
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an approximately 20% reduction in pain, with only slight improvement 
regarding the head position (retrocaput) (Figure 1B). We attempted dif-
ferent combinations of  target muscles. On the basis of  COL-CAP con-
cept, we injected middle scalene, levator scapulae, obliquus capitis 
inferior (OCI), semispinalis capitis, and trapezius muscles, and, based 
on the experience of  other researchers in this form of  CD, both SCM 
and splenius capitis muscles as well. There was no difference in the 
final result between these sessions. We used onabotulinumtoxin A in a 
total dose of  200 U in each session. Because of  unsatisfactory results, 
we decided to inject the longus colli muscle. The patient was placed 
supine on the examination table. The potential risks of  side effects, 
such as bleeding, damage to other structures, or dysphagia, were 
explained to the patient. The longus colli was visualized with a 12.5 
MHz linear US transducer. We decided to use the medial approach via 
the thyroid gland (Figure 2A and B). Using US guidance and an EMG 
A B C
Figure 1. Progress in Patient. (A) Patient before BoNT. (B) Patient at 4 weeks after BoNT injection with only slight improvement regarding retrocaput. (C) Patient 
at 4 weeks after the injection.
A B C
Figure 2. Ways of  Approaching Used in US-guided LCo Injections. (A) Medial approach of  the injection of  LCo via the thyroid gland. (B) Arrows show the 
path of  the needle via the thyroid gland. (C) Lateral approach of  the injection of  LCo via SCM and the anterior scalene muscle.
Figure 3. Simultaneous Use of  Both Methods. Longus colli activation in 
EMG while the patient flexed the neck.
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injection needle (26 G × 50 mm), onabotulinumtoxin A was injected 
15 U per side (Figure 3). The dose was chosen based on the recommen-
dations of  the botulinum toxin atlas and other published experiences, 
in which 60 U of  abobotulinumtoxin A was used on each side,19 30–35 
U of  abobotulinumtoxin A unilaterally,17 or 25 U of  abobotulinum-
toxin A on one side and 10 U on the other side.20 Based on the publi-
cation,19 in which seven patients with “goose neck” dystonia were 
reported, both sternocleidomastoids and splenius capitis presented 
increased dystonic activity on EMG. In addition to both longus colli 
muscles, we also injected both SCM (each 30 U) and both splenius 
capitis (each 30 U). The splenius capitis muscles act as extensors of  the 
head, and there is no risk injecting them to worsen anterocollis. After 4 
weeks, the patient presented significant improvement (Figure 1C). 
There were no side effects.
Discussion
BoNT injections are the first-line of  treatment for CD with a high 
response rate and low incidence of  adverse effects.3–12
Since examinations of  the muscle using imaging techniques were 
started,14 we have witnessed the introduction of  the so-called Col-Cap 
concept, which is the classification of  the phenomenological forms into 
11 variants. Among them, the anterior forms (anterocaput and antero-
collis) are the most difficult to treat15 because of  the deep cervical mus-
cles that are very often involved. Injecting of  these deep lying muscles 
carries the risk of  damage to neighboring structures, such as blood ves-
sels, nerves or the esophagus. ASS is a specific type of  CD involving 
neck flexion (anterocollis) and head extension (retrocaput). The longus 
colli muscle is a deep neck muscle situated on the anterior surface of  the 
vertebral column between the atlas and the third thoracic vertebra. It is 
broad in the middle part and narrow at either end and consists of  three 
portions: A superior and an inferior oblique and a vertical one. The 
Longus Colli muscle (LCo) can be treated under fluoroscopy,16 CT,17,18 
EMG,19 or US20 control approximately at the fifth neck vertebra level by 
BoNT injection in the pars obliqua inferior and the pars recta. In one of  
the studies, neurobotulinum toxin treatment under CT- guided injec-
tions was rated to be good or very good by only three out of  eight 
patients (37.5%) with severe antecaput and/or antecollis.18 Six out of  
eight patients reported on dysphagia, whereas one patient developed a 
small hematoma at the place where the tip of  the needle had been 
inserted, resulting in mild dysphagia. In another paper, one case injected 
with the same guidance was presented, in which treatment was repeated 
several times and the patient reported subjective improvement of  his 
anterocollis of  about 40%.17 Only the second injection led to mild dys-
phagia, which was completely reversible after 4 weeks. No other side 
effects were noted. In another study, a total of  10 injection sessions were 
performed on three patients under fluoroscopy guidance.16 In two 
patients whose main complaint was neck pain, marked improvement in 
pain relief  was observed. In the third patient, who had prominent motor 
symptoms but no pain, a 20–30% motor improvement was reported. All 
patients complained about mild post-procedure injection site discomfort 
and one patient reported a sore throat lasting several days. Swallowing 
difficulties were reported after two of  the 10 injections and were related 
to higher doses of  BoNT. Potential drawbacks in this method of  guid-
ance are X-ray exposure and allergic contrast agent reactions.
Injection of  LCo under EMG guidance can be effective and safe as is 
presented in the published cases19 of  the two double-chin patients with 
bilateral suprahyoid, SCM, and LCo injections. During the review at 4 
weeks postinjection, the mean subjective improvement observed was from 
50 to 80%. Neck flexor weakness was observed in one patient, who com-
plained of  difficulty in lifting her head from the pillow in the first 3 weeks. 
In one case, which applied the same methods, that is, injection of  the LCo 
muscle under both EMG and US control, pain and posture improvement 
without side effects was reported.20 The injection of  the pars obliqua 
superior of  the LCo requires endoscopic guidance.21 There are two per-
cutaneous approaches, the medial and lateral, depending on individual 
patient anatomy. We need US to find the most optimal path to target LCo 
and avoid damaging surrounding structures.23 Using a medial approach, 
we proceed via the thyroid gland, between the carotid sheath and trachea, 
paying close attention to the esophagus, as well as the inferior and supe-
rior thyroid arteries. We have discussed this approach with several ENT 
and radiologist doctors who deal with thyroid gland biopsy. We can addi-
tionally use Doppler technique to visualize arteries and perform labora-
tory tests assessing coagulation system to decrease the risk of  bleeding. 
When approaching the LCo laterally, the needle is guided laterally to the 
carotid sheath but medially to the anterior scalene to avoid traversing the 
phrenic nerve (Figure 2C). The lateral approach is performed going 
through the anterior scalene muscle. The drawback of  this method is that 
the placement of  the EMG needle tip is often not visible, so we need 
EMG as a functional guidance. The patient is positioned supine, and the 
EMG needle is inserted under US control. To check the correct place-
ment of  the needle tip, we ask the patient to flex the neck expecting the 
proper EMG sound reflecting muscle activation. In the case described 
here, we had to change the needle position to a deeper level to get an 
adequate acoustic response. This is the reason why we recommend using 
both EMG and US guidance. Even though both of  these techniques are 
simultaneously in use, we must of  course be aware that the injection of  
longus colli muscle carries some risk, which is why we should try to mini-
mize it. Of  course, numerous cases of  subjects undergoing this procedure 
without adverse effects would make a more reliable and convincing argu-
ment; however, for now, we can share our experience with only one such 
case. Once more subjects have been treated in this way, we will be glad to 
share our observations and conclusions.
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